documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
11 rows where docket_id = "FDA-2010-D-0482" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, last_modified, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 11
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-D-0482-0033 | FDA | None FDA-2010-D-0482 | Guidances for Industry and Investigators; on Safety Reporting Requirements for Investigational New Drug Applications and Bioavailability/ Bioequivalence Studies, and a Small Entity Compliance Guide; Availability | Notice | Notice of Availability | 2012-12-20T05:00:00Z | 2012 | 12 | 2012-12-20T05:00:00Z | 2019-08-22T20:02:45Z | 2012-30651 | 0 | 0 | 0900006481193abb | |
| FDA-2010-D-0482-0034 | FDA | None FDA-2010-D-0482 | Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA BE Studies | Other | Guidance | 2012-12-20T05:00:00Z | 2012 | 12 | 2012-12-20T05:00:00Z | 2024-11-12T05:10:37Z | 1 | 0 | 0900006481193beb | ||
| FDA-2010-D-0482-0035 | FDA | None FDA-2010-D-0482 | Guidances for Industry and Investigators; on Safety Reporting Requirements for Investigational New Drug Applications and Bioavailability/ Bioequivalence Studies, Small Entity Compliance Guide | Other | Guidance | 2012-12-20T05:00:00Z | 2012 | 12 | 2012-12-20T05:00:00Z | 2019-08-22T20:06:38Z | 0 | 0 | 0900006481193bed | ||
| FDA-2010-D-0482-0032 | FDA | None FDA-2010-D-0482 | Minute of the FDA-PhRMA Dialogue, dated September 9, 2011 | Other | Minutes | 2012-04-13T04:00:00Z | 2012 | 4 | 2012-04-13T04:00:00Z | 2019-08-22T20:02:30Z | 0 | 0 | 0900006480feea00 | ||
| FDA-2010-D-0482-0029 | FDA | None FDA-2010-D-0482 | Guidance for Industry and Investigators on Enforcement of Safety Reporting Requirements: Investigational New Drug Applications and Bioavailability/Bioequivalence Studies; Availability | Notice | NAD-Notice of Availability of Data | 2011-06-07T04:00:00Z | 2011 | 6 | 2011-06-07T04:00:00Z | 2011-06-07T15:38:14Z | 2011-13950 | 0 | 0 | 0900006480e3df14 | |
| FDA-2010-D-0482-0030 | FDA | None FDA-2010-D-0482 | Guidance for Industry and Investigators on Enforcement of Safety Reporting Requirements: Investigational New Drug Applications and Bioavailability/Bioequivalence Studies | Other | GDL-Guidance | 2011-06-07T04:00:00Z | 2011 | 6 | 2011-06-07T04:00:00Z | 2019-08-22T20:03:09Z | 0 | 0 | 0900006480e3e2a5 | ||
| FDA-2010-D-0482-0027 | FDA | None FDA-2010-D-0482 | FDA/PhRMA Meeting Minutes | Other | MM-Memorandum of Meeting | 2011-05-05T04:00:00Z | 2011 | 5 | 2011-05-05T04:00:00Z | 2013-07-27T23:52:13Z | 0 | 0 | 0900006480c40227 | ||
| FDA-2010-D-0482-0026 | FDA | None FDA-2010-D-0482 | Pharmaceutical Research and Manufacturers of America (PhRMA) - Letter | Other | LET-Letter | 2011-05-05T04:00:00Z | 2011 | 5 | 2011-05-05T04:00:00Z | 2013-07-27T23:52:13Z | 0 | 0 | 0900006480c40225 | ||
| FDA-2010-D-0482-0025 | FDA | None FDA-2010-D-0482 | New IND Safety Reporting Requirements | Supporting & Related Material | N-Notice (Supporting and Related Material) | 2011-03-28T04:00:00Z | 2011 | 3 | 2011-03-28T13:20:19Z | 0 | 0 | 0900006480c11d39 | |||
| FDA-2010-D-0482-0020 | FDA | None FDA-2010-D-0482 | Safety Reporting Requirements for INDs and BA/BE Studies; Draft Guidance | Other | GDL-Guidance (Supporting and Related Materials) | 2011-01-21T05:00:00Z | 2011 | 1 | 2011-01-21T05:00:00Z | 2017-12-06T02:02:21Z | 0 | 0 | 0900006480b63418 | ||
| FDA-2010-D-0482-0001 | FDA | None FDA-2010-D-0482 | Draft Guidance for Industry and Investigators: Safety Reporting Requirements for Investigational New Drug Applications andBioavailability/Bioequivalence Studies; Availability | Notice | GDL-Guidance | 2010-09-29T04:00:00Z | 2010 | 9 | 2010-09-29T04:00:00Z | 2010-12-29T04:59:59Z | 2010-09-29T15:28:33Z | 2010-24295 | 0 | 0 | 0900006480b63098 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;